United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for BELITE BIO, INC? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
| ROE | -47.95% | -0.16% | -0.16% | -0.16% | -0.16% | -0.16% |
|---|---|---|---|---|---|---|
| ROA | -45.54% | -0.15% | -0.15% | -0.15% | -0.15% | -0.15% |
| Total Assets | $94,642.00K | $94,642.00K | $94,642.00K | $94,642.00K | $94,642.00K | $94,642.00K |
| Net Income | -$31,632.00K | -$140.00K | -$140.15K | -$140.32K | -$140.52K | -$140.75K |